Display options
Cite
Kosilov K, Loparev S, Ivanovskaya M, et al. Maintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly women. Int Neurourol J. 2013;17(4):191-6doi: 10.5213/inj.2013.17.4.191.
Kosilov, K., Loparev, S., Ivanovskaya, M., & Kosilova, L. (2013). Maintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly women. International neurourology journal, 17(4), 191-6. https://doi.org/10.5213/inj.2013.17.4.191
Kosilov, Kirill, et al. "Maintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly women." International neurourology journal vol. 17,4 (2013): 191-6. doi: https://doi.org/10.5213/inj.2013.17.4.191
Kosilov K, Loparev S, Ivanovskaya M, Kosilova L. Maintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly women. Int Neurourol J. 2013 Dec;17(4):191-6. doi: 10.5213/inj.2013.17.4.191. Epub 2013 Dec 31. PMID: 24466467; PMCID: PMC3895512.
Copy Download .nbib Format: NLM
Share it on

Int Neurourol J. 2013 Dec;17(4):191-6. doi: 10.5213/inj.2013.17.4.191. Epub 2013 Dec 31.

Maintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly women.

International neurourology journal

Kirill Kosilov, Sergey Loparev, Marina Ivanovskaya, Liliya Kosilova

Affiliations

  1. Far Eastern Federal University, Vladivostok, Russia.
  2. Department of Urology, City Polyclinic No. 3, Vladivostok, Russia.
  3. Far Eastern State University of Fishing, Vladivostok, Russia.
  4. Medical Alliance No. 2, Vladivostok, Russia.

PMID: 24466467 PMCID: PMC3895512 DOI: 10.5213/inj.2013.17.4.191

Abstract

PURPOSE: To improve the long-term efficiency of the pharmacologic management of overactive bladder (OAB) in elderly women.

METHODS: The study comprised 229 women (mean age, 66.3 years; range, 65-77 years) with urodynamically and clinically confirmed OAB. All patients received the most effective treatment regimen based on the data obtained in the initial part of the study (trospium 60 mg/day + solifenacin 40 mg/day, for 6 weeks), and positive results similar to those in the first phase were obtained. They were then divided into four groups, based on the maintenance therapy: group A (59 women), trospium (60 mg/day) + solifenacin (40 mg/day) for 1 month; group B (51 women), electrical stimulation of the detrusor muscle for 1 month; group C (63 women), laser puncture for 1 month; group D (56 women), placebo. Maintenance therapy was administered 2.5 months after completion of primary treatment. The patients' condition was monitored through the OAB questionnaire for 1 year and by urodynamic examination at months 6 and 7 from the start of the study.

RESULTS: In group A, the clinical and urodynamic results achieved after the initial + main treatment phase (two high-dosage antimuscarinics of different generations, trospium and solifenacin, for a total of 2.5 months) were maintained for at least 7 months. Electrical stimulation of the urinary bladder as a method of maintenance therapy proved to be less effective. In groups C and D, deterioration in results was observed at 6-8 months, which led us to conclude that laser puncture was an inefficient method of maintenance therapy in elderly women with OAB.

CONCLUSIONS: Maintenance treatment of OAB in elderly women with a combination of high-dosage antimuscarinics is an effective method for reducing the risk of recurrence of the disease.

Keywords: Long-term results; Muscarinic antagonists; Older women; Overactive urinary bladder

References

  1. Clin Ther. 2008 Oct;30(10):1766-81 - PubMed
  2. Zhongguo Zhen Jiu. 2007 Jul;27(7):485-7 - PubMed
  3. Urology. 2000 May;55(5A Suppl):17-23; discussion 31-2 - PubMed
  4. J Am Geriatr Soc. 2005 May;53(5):846-50 - PubMed
  5. Obstet Gynecol. 2005 Jul;106(1):138-43 - PubMed
  6. Physiol Meas. 2013 May;34(5):479-86 - PubMed
  7. Neurourol Urodyn. 2002;21(3):261-74 - PubMed
  8. Nihon Hinyokika Gakkai Zasshi. 1995 Oct;86(10):1514-9 - PubMed
  9. Mo Med. 2007 Sep-Oct;104(5):435-9 - PubMed
  10. Clin Interv Aging. 2009;4:191-6 - PubMed
  11. J Urol. 2006 Dec;176(6 Pt 1):2530-4 - PubMed
  12. Int J Clin Pract. 2013 Mar;67(3):198-204 - PubMed
  13. Clin Rehabil. 2010 Apr;24(4):342-51 - PubMed
  14. Prof Nurse. 1999 Dec;15(3):211-4 - PubMed
  15. World J Urol. 2011 Apr;29(2):185-90 - PubMed
  16. Neurourol Urodyn. 2010 Nov;29(8):1365-72 - PubMed
  17. J Am Geriatr Soc. 2010 Sep;58(9):1715-20 - PubMed
  18. Eur J Clin Pharmacol. 2009 Mar;65(3):309-14 - PubMed
  19. Neurourol Urodyn. 2007;26(6):800-6 - PubMed
  20. J Urol. 2012 Dec;188(6 Suppl):2464-72 - PubMed
  21. Korean J Urol. 2010 Dec;51(12):811-8 - PubMed
  22. Urologe A. 2014 Nov;53(11):1633-8 - PubMed
  23. Int J Clin Pract. 2009 Apr;63(4):560-7 - PubMed
  24. Int J Clin Pract. 2010 Oct;64(11):1535-1540 - PubMed
  25. Age Ageing. 2007 May;36(3):349-50 - PubMed
  26. Handb Exp Pharmacol. 2011;(202):319-44 - PubMed
  27. J Am Geriatr Soc. 2011 Aug;59(8):1465-70 - PubMed
  28. Eur Urol. 2008 May;53(5):1021-8 - PubMed
  29. Am J Phys Med Rehabil. 2006 Jun;85(6):536-45 - PubMed
  30. Handb Exp Pharmacol. 2011;(202):171-205 - PubMed
  31. Neurourol Urodyn. 2006;25(5):441-5 - PubMed

Publication Types